热门出版物 - 学术资源搜索

h5 指数:213
h5 中位数:315

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#1 Oncology
#7 Health & Medical Sciences

标题/作者	引用次数	年份
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline JR Brahmer, C Lacchetti, BJ Schneider, MB Atkins, KJ Brassil, ... Journal of Clinical Oncology 36 (17), 1714-1768	2394	2018
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update BR Ferrell, JS Temel, S Temin, ER Alesi, TA Balboni, EM Basch, JI Firn, ... Journal of Clinical Oncology 35 (1), 96-112	1295	2017
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ... Journal of Clinical Oncology 36 (20), 2105-2122	1255	2018
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer MJ Overman, S Lonardi, KYM Wong, HJ Lenz, F Gelsomino, M Aglietta, ... Journal of Clinical Oncology 36 (8), 773-779	1224	2018
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study. C Fitzmaurice, Global Burden of Disease Cancer Collaboration Journal of Clinical Oncology 36 (15_suppl), 1568-1568	1058	2018
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy GW Sledge Jr, M Toi, P Neven, J Sohn, K Inoue, X Pivot, O Burdaeva, ... Journal of Clinical Oncology 35 (25), 2875-2884	1031	2017
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study A Marabelle, DT Le, PA Ascierto, AM Di Giacomo, A De Jesus-Acosta, ... Journal of Clinical Oncology 38 (1), 1-10	1013	2020
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer MP Goetz, M Toi, M Campone, J Sohn, S Paluch-Shimon, J Huober, ... Journal of Clinical Oncology 35 (32), 3638-3646	953	2017
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) AM Young, A Marshall, J Thirlwall, O Chapman, A Lokare, C Hill, D Hale, ... Journal of Clinical Oncology 36 (20), 2017-2023	932	2018
Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ... Journal of Clinical Oncology 36 (7), 633-641	890	2018
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma JS Weber, FS Hodi, JD Wolchok, SL Topalian, D Schadendorf, J Larkin, ... Journal of Clinical Oncology 35 (7), 785-792	887	2017
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline SH Armenian, C Lacchetti, A Barac, J Carver, LS Constine, N Denduluri, ... Journal of Clinical Oncology 35 (8), 893-911	857	2017
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update K Oktay, BE Harvey, AH Partridge, GP Quinn, J Reinecke, HS Taylor, ... Journal of Clinical Oncology 36 (19), 1994-2001	855	2018
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater M Reck, D Rodríguez–Abreu, AG Robinson, R Hui, T Csőszi, A Fülöp, ... Journal of Clinical Oncology 37 (7), 537-546	852	2019
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma R Chen, PL Zinzani, MA Fanale, P Armand, NA Johnson, P Brice, ... Journal of Clinical Oncology 35 (19), 2125-2132	816	2017
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology SG Mohile, W Dale, MR Somerfield, MA Schonberg, CM Boyd, ... Journal of Clinical Oncology 36 (22), 2326-2347	772	2018
Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy J Naidoo, X Wang, KM Woo, T Iyriboz, D Halpenny, J Cunningham, ... Journal of Clinical Oncology 35 (7), 709-717	753	2017
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial P Ost, D Reynders, K Decaestecker, V Fonteyne, N Lumen, A De Bruycker, ... Journal of Clinical Oncology 36 (5), 446-453	748	2018
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update NS Key, AA Khorana, NM Kuderer, K Bohlke, AYY Lee, JI Arcelus, ... Journal of Clinical Oncology 38 (5), 496-520	733	2020
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial RS Finn, BY Ryoo, P Merle, M Kudo, M Bouattour, HY Lim, V Breder, ... Journal of Clinical Oncology 38 (3), 193-202	726	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。